openPR Logo
Press release

New update "Global Ankylosing Spondylitis Market 2015-2019" The Report covers an In-depth Market Trends, Worldwide Analysis, Forecast, Review, Share, Size, Growth, Effect.

12-01-2016 03:03 PM CET | Health & Medicine

Press release from: RMOZ - Research Reports

"Global Ankylosing Spondylitis Market 2015-2019" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

About Ankylosing Spondylitis

Ankylosing spondylitis is a subtype of spondylarthropathy. The primary symptoms of the disease are inflammatory spinal pain with subsequent limitation of spine mobility and chest expansion. Ankylosing spondylitis can be diagnosed using clinical signs, radiological signs (sacroiliitis) and the presence of HLA-B27 antigen. According to the NIH and NIAMS, ankylosing spondylitis is a type of arthritis, which affects the joints in the vertebral column severely.

Get Sample Report With TOC @ https://goo.gl/hUZY87

It is a progressive inflammatory disease that typically becomes evident during early to mid-adulthood, as per NORD. It can also lead to the loss of spinal mobility for the affected individuals. The cause of the disease is not known, however, the HLA-B27 gene plays a major role. Ankylosing spondylitis is hereditary in nature.

TechNavio's analysts forecast the Global Ankylosing Spondylitis market to grow at a CAGR of 5.05 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Ankylosing Spondylitis market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of ankylosing spondylitis. The market is segmented based on the mechanism of action of the drugs used to treat ankylosing spondylitis as illustrated below:

TNF Inhibitors

COX Inhibitors

Others

On the type of molecule used for the treatment of ankylosing spondylitis, as illustrated below:

Biologics

Small Molecules

On the basis of route of administration adopted for the treatment of ankylosing spondylitis, the Global Ankylosing Spondylitis market is segmented as follows:

Oral

Parenteral

In addition, the market is also bifurcated on the basis of dosage forms of the drugs used in the treatment of the disease:

Solid

Liquid

The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Also, the late-stage pipeline molecules developed for the treatment of Ankylosing Spondylitis have been discussed.

Global Ankylosing Spondylitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region and the EMEA; it also covers the Global Ankylosing Spondylitis market landscape and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market.

Key Regions

Americas

APAC

EMEA

Key Vendors

Abbvie

Amgen

Janssen Pharmaceuticals

Merck & Co.

Pfizer

Other Prominent Vendors

Boehringer Ingelheim

Bristol-Myers Squibb

Celgene

Celltrion

Eisai

F. Hoffmann-La Roche

Merck Sharp & Dohme

Novartis

Otsuka Pharmaceutical

Regeneron Pharmaceuticals

Sanofi

Shanghai Pharmaceuticals

UCB

Market Driver

Presence of Unmet Need

For a full, detailed list, view our report

Market Challenge

Threat from Patent Expiry

For a full, detailed list, view our report

Market Trend

Market Dominance by Biologics

For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2019 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New update "Global Ankylosing Spondylitis Market 2015-2019" The Report covers an In-depth Market Trends, Worldwide Analysis, Forecast, Review, Share, Size, Growth, Effect. here

News-ID: 389892 • Views:

More Releases from RMOZ - Research Reports

Key Questions Answered By Urinary Slings Market 2016
"Urinary Slings Market in the US 2015-2019" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- About Urinary Incontinence Slings Urinary incontinence slings are flexible surgical mesh systems that are placed surgically to restore the urethra to its normal position and efficiently minimize incontinence. A sling procedure uses strips of the bodys tissue or synthetic mesh to create a hammock-like fixture that wraps around the bladder
New update "Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Revi …
"Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016" The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. Description- GlobalData's clinical trial report, Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016" provides an overview of Severe Acute Respiratory Syndrome (SARS) clinical trials scenario. This report provides top line data relating to the clinical trials on Severe Acute Respiratory Syndrome (SARS). Report includes an
New update "Liver Transplant Rejection Global Clinical Trials Review, H2, 2016" …
"Liver Transplant Rejection Global Clinical Trials Review, H2, 2016" The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. Description- GlobalData's clinical trial report, Liver Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Liver Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Transplant Rejection. Get Sample Report With TOC @ https://goo.gl/VuZVV2 Report includes an overview of trial

All 4 Releases


More Releases for Ankylosing

Ankylosing Spondylitis Medication Market Size And Global Industry Forecast 2034
"As of 2024, the global ankylosing spondylitis (AS) medication market is valued at approximately $5 billion, driven by an increasing prevalence of the condition and a growing awareness of treatment options. The market is projected to reach roughly $9 billion by 2034, reflecting a robust growth trajectory over the next decade. The anticipated Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at around
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate? The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638 Introduction: The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively. Unveiling Ankylosing
Ankylosing Spondylitis Treatment Market to Witness Astonishing Growth by 2029
This Ankylosing Spondylitis Treatment Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Ankylosing Spondylitis Treatment Market study report.
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/ Retail Pharmacy to Dominate the
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631 Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen